Medindia
Medindia LOGIN REGISTER
Advertisement

OnCure Holdings, Inc. Agrees To Sell Its Businesses Through Chapter 11 Proceedings

Monday, June 24, 2013 Corporate News
Advertisement
OnCure Holdings, Inc. and certain of its affiliates, leading providers of management services and facilities to radiation oncology physician groups, previously announced an agreement in principle for the sale of its businesses.  OnCure is pleased to announce that it has entered into an investment agreement with Radiation Therapy Services, Inc. ("RTS") under which RTS has agreed to acquire OnCure for approximately $125 million, including $42.5 million in cash (plus covering certain expenses and subject to certain working capital adjustments) and up to $82.5 million in assumed debt.  In addition, OnCure's secured noteholders have executed a restructuring support agreement outlining their commitment to support the transaction with RTS.
Advertisement

On June 14, 2013, OnCure commenced reorganization cases under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.  With the execution of the investment agreement, RTS has agreed to be the lead bidder in a sale process to take place during the chapter 11 cases.  If RTS's bid is successful and receives Bankruptcy Court approval, the acquisition will be completed through OnCure's chapter 11 plan of reorganization, which is expected to occur prior to the end of October 2013.
Advertisement

On June 18, 2013, the Bankruptcy Court approved OnCure's $25 million debtor in possession credit facility on an interim basis and other relief related to the continued operation of its businesses.

OnCure's legal advisors in connection with its restructuring are Latham & Watkins LLP and Richards, Layton & Finger, P.A.  Financial advisory services are being provided by Jefferies LLC. Match Point Partners LLC is providing management services to OnCure.

For more information on OnCure, please visit www.oncure.com.  For more information on OnCure's bankruptcy case, please visit www.kccllc.net/oncure, email [email protected], or call the case-dedicated toll-free phone number at (877) 634-7166.

SOURCE OnCure Holdings, Inc.

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close